Andrew D. Campbell

6.3k total citations · 1 hit paper
67 papers, 1.9k citations indexed

About

Andrew D. Campbell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Andrew D. Campbell has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 18 papers in Cellular and Molecular Neuroscience and 15 papers in Oncology. Recurrent topics in Andrew D. Campbell's work include Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Andrew D. Campbell is often cited by papers focused on Receptor Mechanisms and Signaling (13 papers), Neuropeptides and Animal Physiology (9 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Andrew D. Campbell collaborates with scholars based in United Kingdom, United States and Germany. Andrew D. Campbell's co-authors include William J. McBride, Owen J. Sansom, Jennifer P. Morton, Simon T. Barry, R. Kohl, Dmitry I. Gabrilovich, Richard J. K. Taylor, Oren Bogin, Willem P.C. Stemmer and Yong Yin and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature reviews. Cancer.

In The Last Decade

Andrew D. Campbell

65 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic targeting of tumour myeloid cells

2023 168 citations Simon T. Barry, Dmitry I. Gabrilovich et al. Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew D. Campbell United Kingdom	24	1.1k	373	339	227	213	67	1.9k
Christine Huang United States	20	840 0.7×	406 1.1×	212 0.6×	274 1.2×	200 0.9×	47	1.7k
Chenbo Zeng United States	29	1.8k 1.6×	417 1.1×	287 0.8×	92 0.4×	292 1.4×	40	2.4k
Yichin Liu United States	21	1.3k 1.2×	259 0.7×	404 1.2×	116 0.5×	145 0.7×	33	2.3k
Huw D. Lewis United Kingdom	23	921 0.8×	329 0.9×	276 0.8×	176 0.8×	163 0.8×	46	2.1k
Mayra Paolillo Italy	24	981 0.9×	319 0.9×	320 0.9×	163 0.7×	77 0.4×	51	1.7k
Monique Dontenwill France	32	2.0k 1.8×	857 2.3×	392 1.2×	244 1.1×	225 1.1×	123	3.0k
Tetsuya Fukuda Japan	32	1.2k 1.0×	410 1.1×	527 1.6×	833 3.7×	267 1.3×	136	3.2k
James I. MacDonald Canada	24	1.1k 1.0×	303 0.8×	267 0.8×	58 0.3×	223 1.0×	38	1.6k
Heung‐Chin Cheng Australia	29	2.3k 2.0×	464 1.2×	359 1.1×	241 1.1×	132 0.6×	71	3.0k
Xin-Yun Huang United States	24	2.2k 1.9×	499 1.3×	480 1.4×	468 2.1×	335 1.6×	27	3.4k

Countries citing papers authored by Andrew D. Campbell

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Campbell more than expected).

Fields of papers citing papers by Andrew D. Campbell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Campbell. The network helps show where Andrew D. Campbell may publish in the future.

Co-authorship network of co-authors of Andrew D. Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Campbell. A scholar is included among the top collaborators of Andrew D. Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Campbell. Andrew D. Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ling, Stephanie, Alex Dexter, Alan Race, et al.. (2025). Use of metabolic imaging to monitor heterogeneity of tumour response following therapeutic mTORC1/2 pathway inhibition. Disease Models & Mechanisms. 18(2). 2 indexed citations

Najumudeen, Arafath K., Sigrid K. Fey, Catriona A. Ford, et al.. (2024). KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo. Nature Communications. 15(1). 100–100. 8 indexed citations

Malviya, Gaurav, Tamsin R.M. Lannagan, Emma Johnson, et al.. (2024). Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging. Clinical Cancer Research. 30(8). 1518–1529. 2 indexed citations

Fey, Sigrid K., Arafath K. Najumudeen, Catriona A. Ford, et al.. (2024). KRAS Loss of Heterozygosity Promotes MAPK-Dependent Pancreatic Ductal Adenocarcinoma Initiation and Induces Therapeutic Sensitivity to MEK Inhibition. Cancer Research. 85(2). 251–262. 4 indexed citations

Chen, Fuhui, David Novo, Çiğdem Selli, et al.. (2023). RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells. Oncogene. 42(9). 679–692. 8 indexed citations

Barry, Simon T., Dmitry I. Gabrilovich, Owen J. Sansom, Andrew D. Campbell, & Jennifer P. Morton. (2023). Therapeutic targeting of tumour myeloid cells. Nature reviews. Cancer. 23(4). 216–237. 168 indexed citations breakdown →

Amirkhah, Raheleh, James G. Jackson, Tamsin R.M. Lannagan, et al.. (2022). Molecular Subtyping Resource: a user-friendly tool for rapid biological discovery from transcriptional data. Disease Models & Mechanisms. 15(3). 3 indexed citations

Yu, Yachuan, Álvaro Román‐Fernández, Emma Sandilands, et al.. (2021). RAL GTPases mediate EGFR-driven intestinal stem cell proliferation and tumourigenesis. eLife. 10. 13 indexed citations

Weyden, Louise van der, Victoria Harle, Victoria Offord, et al.. (2021). CRISPR activation screen in mice identifies novel membrane proteins enhancing pulmonary metastatic colonisation. Communications Biology. 4(1). 395–395. 12 indexed citations

10.

Joseph, John, Amir Moradi, Z. Paul Lorenc, et al.. (2021). AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study. Journal of Drugs in Dermatology. 20(9). 980–987. 13 indexed citations

11.

Swaminathan, Karthic, Andrew D. Campbell, Vassilis Papalazarou, et al.. (2020). The RAC1 Target NCKAP1 Plays a Crucial Role in the Progression of Braf;Pten-Driven Melanoma in Mice. Journal of Investigative Dermatology. 141(3). 628–637.e15. 12 indexed citations

12.

Khawaja, Hajrah, Andrew D. Campbell, Jamie Z. Roberts, et al.. (2020). RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancer. Cell Death and Disease. 11(10). 930–930. 14 indexed citations

13.

Clayton, Anita H., Robert Lasser, Indrani Nandy, et al.. (2020). SAGE-217 in Major Depressive Disorder: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial (705). Neurology. 94(15_supplement). 1 indexed citations

14.

Ridgway, Rachel A., Miryam Müller, Michael C. Hodder, et al.. (2019). Author Correction: Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer (Nature Communications, (2019), 10, 1, (723), 10.1038/s41467-019-08586-3). Nature Communications. 10(1). 1 indexed citations

15.

Kaymak, Irem, Werner Schmitz, Andrew D. Campbell, et al.. (2019). Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress. Cancer Research. 80(2). 189–203. 66 indexed citations

16.

Rainero, Elena, Emmanuel Dornier, Louise Mitchell, et al.. (2017). Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion. Nature Communications. 8(1). 14646–14646. 38 indexed citations

17.

Nobis, Max, Ewan J. McGhee, Jennifer P. Morton, et al.. (2013). Intravital FLIM-FRET Imaging Reveals Dasatinib-Induced Spatial Control of Src in Pancreatic Cancer. Cancer Research. 73(15). 4674–4686. 99 indexed citations

18.

Mestek, Anton, Joyce H. Hurley, Andrew D. Campbell, et al.. (1995). The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. PMC. 1 indexed citations

19.

Mestek, Anton, Yan Chen, Joyce H. Hurley, et al.. (1994). The μ opioid receptor: Cellular function and tolerance development. Regulatory Peptides. 54(1). 193–194. 2 indexed citations

20.

Young, Paul & Andrew D. Campbell. (1982). The synthesis of a dipeptide from its component amino acids: Protecting groups in the elementary organic laboratory. Journal of Chemical Education. 59(8). 701–701. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact